Literature DB >> 7672144

Metabolism of dihydrotestosterone to 5 alpha-androstane-3 alpha, 17 beta-diol glucuronide is greater in the peripheral compartment than in the splanchnic compartment.

D M Duffy1, R S Legro, L Chang, F Z Stanczyk, R A Lobo.   

Abstract

OBJECTIVE: To compare the peripheral versus the splanchnic contribution to the formation of 3 alpha-diol G.
DESIGN: Prospective study in various groups of women and men.
SETTING: Reproductive Endocrine service of our University Medical Center. PATIENTS: Six normal ovulatory women, five hirsute women with polycystic ovary syndrome, and six normal men.
INTERVENTIONS: All subjects received IV dihydrotestosterone (DHT) infusions as well as percutaneous administration of DHT. Serum was obtained at multiple time points before and after each administration of DHT. MAIN OUTCOME MEASURES: Comparison of serum levels of DHT, 3 alpha-androstanediol (3 alpha-diol), 3 alpha-diol G, and androsterone glucuronide in the three groups.
RESULTS: Steady-state levels of DHT were similar in the three groups and were also similar after the two different routes of administration. However, ratios of 3 alpha-diol G to DHT were significantly greater after percutaneous gel than after IV administration in all three groups. This also was the case for the ratio of unconjugated serum 3 alpha-diol to DHT. Levels of androsterone glucuronide were similar with the different routes of administration.
CONCLUSION: Using normal routes of administration and, in attempting to assess in vivo metabolism of DHT, our data confirm that the skin is the major site of unconjugated 3 alpha-diol and 3 alpha-diol G formation. Serum 3 alpha-diol G, therefore, appears largely to reflect skin DHT metabolism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7672144     DOI: 10.1016/s0015-0282(16)57848-0

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

Review 1.  Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels.

Authors:  Ronald S Swerdloff; Robert E Dudley; Stephanie T Page; Christina Wang; Wael A Salameh
Journal:  Endocr Rev       Date:  2017-06-01       Impact factor: 19.871

2.  Relationship of sex steroid hormones with body size and with body composition measured by dual-energy X-ray absorptiometry in US men.

Authors:  Britton Trabert; Barry I Graubard; Sarah J Nyante; Nader Rifai; Gary Bradwin; Elizabeth A Platz; Geraldine M McQuillan; Katherine A McGlynn
Journal:  Cancer Causes Control       Date:  2012-09-28       Impact factor: 2.506

3.  [Spironolactone in dermatological treatment. On and off label indications].

Authors:  C M Salavastru; K Fritz; G S Tiplica
Journal:  Hautarzt       Date:  2013-10       Impact factor: 0.751

4.  Androgen receptor agonists increase lean mass, improve cardiopulmonary functions and extend survival in preclinical models of Duchenne muscular dystrophy.

Authors:  Suriyan Ponnusamy; Ryan D Sullivan; Dahui You; Nadeem Zafar; Chuan He Yang; Thirumagal Thiyagarajan; Daniel L Johnson; Maron L Barrett; Nikki J Koehler; Mayra Star; Erin J Stephenson; Dave Bridges; Stephania A Cormier; Lawrence M Pfeffer; Ramesh Narayanan
Journal:  Hum Mol Genet       Date:  2017-07-01       Impact factor: 6.150

5.  3alpha-Hydroxysteroid dehydrogenase type III deficiency: a novel mechanism for hirsutism.

Authors:  Anne Z Steiner; Lilly Chang; Qing Ji; Murad Ookhtens; Andrew Stolz; Richard J Paulson; Frank Z Stanczyk
Journal:  J Clin Endocrinol Metab       Date:  2008-02-05       Impact factor: 5.958

6.  Proposed mechanism for sperm chromatin condensation/decondensation in the male rat.

Authors:  John C Chapman; Sandra D Michael
Journal:  Reprod Biol Endocrinol       Date:  2003-02-11       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.